REGOMA-OSS: A LARGE, ITALIAN, MULTICENTER, PROSPECTIVE, OBSERVATIONAL STUDY EVALUATING THE EFFICACY AND SAFETY OF REGORAFENIB IN PATIENTS WITH RECURRENT GLIOBLASTOMA
/0 Commenti/in ARTICOLI SCIENTIFICI, NEWS, NEWS IN HOME/da LuisaSAVE THE DATE-2024 CARCINOMA METASTATICO:QUALI NOVITA’? 11 OTTOBRE 2024 ROMA
/0 Commenti/in EVENTI, NEWS, NEWS IN HOME/da Luisa27 MAGGIO 2024-PADUA MASTERCLASS IN NEURO-ONCOLOGY
/0 Commenti/in EVENTI, NEWS, NEWS IN HOME/da Luisa4° CONGRESSO RETE SENOLOGICA TOSCANA 7-8 GIUGNO 2024, CORTONA
/0 Commenti/in EVENTI, NEWS IN HOME, PATROCINIO/da LuisaFRUQUINTINIB VERSUS PLACEBO IN PATIENTS WITH REFRACTORY METASTATIC COLORECTAL CANCER (FRESCO-2): AN INTERNATIONAL, MULTICENTRE, RANDOMISED, DOUBLE-BLIND, PHASE 3 STUDY.
/0 Commenti/in ARTICOLI SCIENTIFICI, NEWS IN HOME, Uncategorized/da LuisaELACESTRANT (ORAL SELECTIVE ESTROGEN RECEPTOR DEGRADER) VERSUS STANDARD ENDOCRINE THERAPY FOR ESTROGEN RECEPTOR-POSITIVE, HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR 2-NEGATIVE ADVANCED BREAST CANCER: RESULTS FROM THE RANDOMIZED PHASE III EMERALD TRIAL.
/0 Commenti/in ARTICOLI SCIENTIFICI, NEWS IN HOME/da LuisaVENERDI 10-SABATO 11 MAGGIO 2024 NEGRAR DI VALPOLICELLA (VR) SCUOLA DI METODOLOGIA CLINICA
/0 Commenti/in EVENTI, NEWS, NEWS IN HOME/da LuisaGIOVEDI 9 MAGGIO 2024 NEGRAR DI VALPOLICELLA (VR) SCUOLA DI METODOLOGIA DELLA RICERCA CLINICA
/0 Commenti/in EVENTI, NEWS, NEWS IN HOME/da LuisaRIPRETINIB IN PATIENTS WITH ADVANCED GASTROINTESTINAL STROMAL TUMOURS (INVICTUS): A DOUBLE-BLIND, RANDOMISED, PLACEBO-CONTROLLED, PHASE 3 TRIAL
/0 Commenti/in ARTICOLI SCIENTIFICI, NEWS IN HOME/da LuisaAIGOM
Associazione italiana gruppi oncologici multidisciplinari
Via Mameli 3, 16122 Genova
mail: info@aigom.it
segreteria@aigom.it
Health Media Srl
Carlo Buffoli e Gino Di Mare
mail: info@healthmedia.it
C.F. 95237450101